--- title: "New Stock News | Authentic Brands Holdings submitted an application to the Hong Kong Stock Exchange, ranking first in retail value for deer-related health supplements and products in Hong Kong in 2024" description: "Zhengpin Holdings Limited has submitted a listing application to the Hong Kong Stock Exchange, planning to go public in Hong Kong in 2024. The company focuses on the development and sales of health an" type: "news" locale: "en" url: "https://longbridge.com/en/news/250668570.md" published_at: "2025-07-29T22:49:04.000Z" --- # New Stock News | Authentic Brands Holdings submitted an application to the Hong Kong Stock Exchange, ranking first in retail value for deer-related health supplements and products in Hong Kong in 2024 > Zhengpin Holdings Limited has submitted a listing application to the Hong Kong Stock Exchange, planning to go public in Hong Kong in 2024. The company focuses on the development and sales of health and beauty supplements, with a market share of approximately 1.6%. According to Frost & Sullivan, Zhengpin Holdings ranks first in the retail value of deer-related health supplements in 2024, with a market share of 29.4%. Its own brand "Yantongxiao" is one of the best-selling products in Mannings retail stores According to the Hong Kong Stock Exchange's disclosure on July 29, Zhengpin Holdings Limited has submitted a listing application to the main board of the Hong Kong Stock Exchange, with Hongbo Capital Limited as its sole sponsor. ![68b5f25ced4c15bd3e6a9513408d2fa.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20250730/1753828865858281.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg) The prospectus shows that Zhengpin Holdings is primarily engaged in the development, sales, marketing, and distribution of health and beauty supplements and products in Hong Kong. The group outsources the production of its products to suppliers (including manufacturers) and mainly distributes its products through Mannings retail stores in Hong Kong under the group's own brands and third-party brands. According to Frost & Sullivan, based on the retail value of health and beauty supplements and products in 2024, the group ranks seventh among all local health and beauty supplement and product suppliers in Hong Kong, with a market share of approximately 1.6%. In the local health and beauty supplement and product market, the group has a diversified product portfolio that meets the needs of men, women, and children of all ages, focusing on the niche market of deer-related health supplements, joint and pain relief products, and topical pain relief products. According to Frost & Sullivan, (i) the group ranks first in the retail value of deer-related health supplements and products in Hong Kong in 2024, with a market share of approximately 29.4%; and (ii) the group's own brand "Yantongxiao" includes joint and pain relief products and topical pain relief products, which are among the top five best-selling joint and pain relief supplements and products in Mannings retail stores in 2024. As of the last practical date, the group operates a total of six own brands, namely (a) "Zhengpin"; (b) "Yantongxiao"; (c) "Organicpharm"; (d) "Riyuetan"; (e) "Weizai Sheng"; and (f) "Profix"; and a total of six third-party brands, including (among others) (a) "iPro+"; and (b) "Boiron". Zhengpin Holdings' products are mainly divided into two categories: (i) health supplements and products; and (ii) beauty supplements and products. During the track record period, the sales of health and beauty supplements and products accounted for approximately 98.8%, 98.8%, and 98.2% of the group's total revenue, respectively. According to Frost & Sullivan, the market for health and beauty supplements and products operated by the group is highly competitive and fragmented. In 2024, the competition in the health and beauty supplement and product market in Hong Kong is relatively intense, with the top ten health and beauty supplement and product suppliers accounting for a total market share of 55.3% based on retail value. In terms of finances, for the fiscal years 2023, 2024, and 2025, the group achieved revenues of approximately HKD 43 million, HKD 110 million, and HKD 130 million, respectively; during the same period, the annual profit and total comprehensive income were approximately HKD 11.313 million, HKD 35.483 million, and HKD 36.257 million, respectively According to the risk factors section of the prospectus by Zhengpin Holdings, the group faces the risk of relying on dairy companies to resell products to end customers, and failing to maintain relationships with dairy companies or otherwise expand the group's wholesale network could have a significant adverse impact on its business ### Related Stocks - [HKXCY.US - Hong Kong Exchanges and Clearing (HKEX)](https://longbridge.com/en/quote/HKXCY.US.md) - [00388.HK - HKEX](https://longbridge.com/en/quote/00388.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 九天四家餐企申请 IPO,港股的窗口期还有多久? | 九天内四家餐饮企业向港交所申请上市,标志着内地餐饮行业在经历三年空窗期后重返资本市场。包括 COMMUNE、袁记食品、比格披萨等品牌在内的企业纷纷递交申请,显示出港股的相对宽松上市条件吸引了众多企业。尽管市场对餐饮企业的上市热情高涨,但分析 | [Link](https://longbridge.com/en/news/274445950.md) | | 香港交易所(388.HK):前高承压上下反复,成交能否放量成关键 | 香港交易所昨日盘中多次上冲前期高位,最终收盘小幅上涨,由于整体成交未显著放量,短线步伐略显谨慎。大市交投气氛回暖,北向资金再现净流入,推动早盘表现积极。港交所作为市场核心标的,一直是主动资金关注的重点,尤其在新股上市消息刺激下,权重轮动现象 | [Link](https://longbridge.com/en/news/274124602.md) | | 特朗普暗示违法征收的关税不退了,美财长称今年关税收入将 “基本保持不变” | 美国总统特朗普暗示不会退还被最高法院裁定违法的关税,预计 2026 年关税收入将保持不变。特朗普计划签署行政令,对全球商品加征 10% 进口关税,取代被推翻的关税。财长贝森特表示,政府将利用替代法律权力维持关税收入,强调国家安全和财政收入不 | [Link](https://longbridge.com/en/news/276494362.md) | | 美财政部让步,拟修订主权财富基金税收提案,此前遭私募业警告 | 美国财政部正就一项针对主权财富基金和公共养老基金征税方式进行全面改革的提案作出让步。相关提案此前由美国国税局提出,拟更新税法第 892 条,将这些基金持有的多数美国债务投资归为商业活动,这将令其面临被征税的风险。此前,私募信贷和私募股权公司 | [Link](https://longbridge.com/en/news/276491732.md) | | Adamas Trust Pref Share ADAMM 7.875 Perp 01/15/25|10-K:2025 财年营收 6.02 亿美元 | | [Link](https://longbridge.com/en/news/276492616.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.